Basil Olive Oil Flavored Tortilla Seasoning Package Type: Box with liner, Units Per Case: 1, Weight Per Package: 50 pounds
⚠ Critical Alert — Stop Using Immediately
This product has been flagged with severe risks (undeclared allergen). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1330-2019.
Elite Spice, Inc. has initiated a recall of Basil Olive Oil Flavored Tortilla Seasoning, Lot Number:1-310242, Units Per Case: 1, Weight Per Package: 50 pounds because Elite Spice produced a batch of seasoning containing an undeclared milk allergen .
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1330-2019.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact Elite Spice Inc. or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1330-2019.
Elite Spice Inc.
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
Elite Spice Inc. Recall FAQ
Elite Spice Inc. is the subject of a food safety report: Basil Olive Oil Flavored Tortilla Seasoning Package Type: Box with liner, Units Per Case: 1, Weight Per Package: 50 pounds. The notice was published on March 1, 2019 by the U.S. Food and Drug Administration (FDA). Approximately 10 units are potentially affected.